![7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one structure, CAS 284028-90-6](/structures/100000/90698_1_284028_90_6.png)
CAS Number284028-90-6
Synonyms2-Methyl-1,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one; 3,5,7,8-Tetrahydro-2-methyl-4H-thiopyrano[4,3-d]pyrimidin-4-one; 2-methyl-3,5,7,8-tetrahydrothiopyrano(4,3-d)pyrimidine-4-one; 7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one; DR 2313; 1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE; 2-Methyl-1-sulfanyl-1H,4H,5H,7H,8H-pyrano[4,3-d]pyriMidin-4-one; 3,5,7,8-tetrahydro-2-methyl-4h-thiopyrano(4,3-d)pyrimidin-4-one
Molecular FormulaC8H10N2OS
Molecular Weight182.25
Density1.5±0.1 g/cm3
Boiling Point349.3±52.0 °C at 760 mmHg
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 284028-90-6 |
| Catalog No. | 2A-9090698 |
| Chinese Name | 3,5,7,8-四氢-2-甲基-4H-硫代吡喃并[4,3-D]嘧啶-4-酮 |
| Synonyms | 2-Methyl-1,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one; 3,5,7,8-Tetrahydro-2-methyl-4H-thiopyrano[4,3-d]pyrimidin-4-one; 2-methyl-3,5,7,8-tetrahydrothiopyrano(4,3-d)pyrimidine-4-one; 7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one; DR 2313; 1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE; 2-Methyl-1-sulfanyl-1H,4H,5H,7H,8H-pyrano[4,3-d]pyriMidin-4-one; 3,5,7,8-tetrahydro-2-methyl-4h-thiopyrano(4,3-d)pyrimidin-4-one |
| Molecular Formula | C8H10N2OS |
| Molecular Weight | 182.25 |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 349.3±52.0 °C at 760 mmHg |
| Storage Condition | 2~8°C |
| Application | DR2313 is a potent, selective, competitive and brain-penetrating inhibitor of polyADP-ribose polymerase (PARP), with IC50s of 0.20μM and 0.24μM for PARP-1 and PARP-2, respectively. DR2313 has neuropro |
| HTC | 2934999090 |
| PubChem ID | 15219719 |
| MDL Number | C8H10N2OS |
| InChI | InChI=1S/C8H10N2OS/c1-5-9-7-2-3-12-4-6(7)8(11)10-5/h2-4H2,1H3,(H,9,10,11) |
| InChI Key | HRYKZAKEAVZGJD-UHFFFAOYSA-N |
| Hazard Symbols | transportation |
| MSDS | msds/90698_1_284028_90_6.pdf |
| Bioactivity | DR2313 is a potent, selective, competitive and brain-penetrant inhibitor of poly(ADP-ribose) polymerase (PARP), with IC50s of 0.20 μM and 0.24 μM for PARP-1 and PARP-2, respectively. DR2313 exhibits neuroprotective effects on ischemic injuries in vitro and in vivo[1][2]. Related Catalog Signaling Pathways >> Epigenetics >> PARP Research Areas >> Neurological Disease Signaling Pathways >> Cell Cycle/DNA Damage >> PARP Target PARP-1:0.20 μM (IC50) PARP-2:0.24 μM (IC50) In Vitro DR2313 (0.016-16.4 μM; 30 min) inhibits poly(ADP-ribosyl)ation reaction in nuclear extracts of rat brain, with a Ki of 0.23 μM[1]. DR2313 shows more powerful inhibition of the poly(ADP-ribosyl)ation in the nuclear extracts of the rat brain (IC50=0.20 μM) than 3AB (35.4 μM), PND (0.56 μM), DIQ (2.96 μM), and DPQ (0.96 μM)[1]. DR2313 (1-100 μM; 10 min) shows a weak inhibition of the mono(ADP-ribosyl)ation in a concentration-dependent manner (IC50=59 μM)[1]. DR2313 (0.1-30 μM; pretreated for 30 min) reduces hydrogen peroxide (500 μM; 4 h) or glutamate (1 mM; 30 min) induced excessive formation of poly(ADP-ribose) and cell death[1]. In Vivo DR2313 (3-10 mg/kg i.v. bolus or infusion for 6 h) significantly reduces the cortical infarct volume in both permanent and transient focal ischemia models in rats[1]. Animal Model: Male Wistar rats (220-300 g) with permanent MCA occlusions (pMCAos) and transient MCA occlusions (tMCAos)[1] Dosage: 3, 10 mg/kg Administration: I.v. bolus and i.v. infusion for 6 h beginning 5 min before the onset of ischemia Result: Reduced the infarct volume in a dose-dependent manner in pMCAo and tMCAo model. References [1]. Nakajima H, et, al. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. J Pharmacol Exp Ther. 2005 Feb;312(2):472-81. [2]. Xu Z, et, al. Endonuclease G does not play an obligatory role in poly(ADP-ribose) polymerase-dependent cell death after transient focal cerebral ischemia. Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R215-21. Chemical & Physical Properties Density 1.5±0.1 g/cm3 Boiling Point 349.3±52.0 °C at 760 mmHg Molecular Formula C8H10N2OS Molecular Weight 182.243 Flash Point 165.0±30.7 °C Exact Mass 182.051376 PSA 71.05000 LogP 0.66 Vapour Pressure 0.0±0.8 mmHg at 25°C Index of Refraction 1.714 Storage condition 2~8°C |
| Use of | DR2313 is a potent, selective, competitive and brain-penetrant inhibitor of poly(ADP-ribose) polymerase (PARP), with IC50s of 0.20 μM and 0.24 μM for PARP-1 and PARP-2, respectively. DR2313 exhibits neuroprotective effects on ischemic injuries in vitro and in vivo[1][2]. Properties Name 7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one Synonym More Synonyms DR 2313 Biological Activity Description DR2313 is a potent, selective, competitive and brain-penetrant inhibitor of poly(ADP-ribose) polymerase (PARP), with IC50s of 0.20 μM and 0.24 μM for PARP-1 and PARP-2, respectively. DR2313 exhibits neuroprotective effects on ischemic injuries in vitro and in vivo[1][2]. Related Catalog Signaling Pathways >> Epigenetics >> PARP Research Areas >> Neurological Disease Signaling Pathways >> Cell Cycle/DNA Damage >> PARP PARP-1:0.20 μM (IC50) PARP-2:0.24 μM (IC50) References [1]. Nakajima H, et, al. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. J Pharmacol Exp Ther. 2005 Feb;312(2):472-81. [2]. Xu Z, et, al. Endonuclease G does not play an obligatory role in poly(ADP-ribose) polymerase-dependent cell death after transient focal cerebral ischemia. Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R215-21. Chemical & Physical Properties Molecular Formula C8H10N2OS Exact Mass 182.051376 PSA 71.05000 Index of Refraction 1.714 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Dibenzo[b,e]oxepine-6,11-dione | 15128-50-4 | 2A-9090672 |
| N-[(4-aminio(2-pyridyl))methyl](tert-butoxy)-N-(methylethyl)carboxamide | 1240620-35-2 | 2A-9090673 |
| MARFEY'S REAGENT | 95713-52-3 | 2A-9090675 |
| 1-(3,3-dimethylmorpholin-4-yl)-2-chloroethan-1-one | 1251099-95-2 | 2A-9090678 |
| 3-Methylamino-4-nitro-benzoicacidmethylester | 251643-13-7 | 2A-9090696 |
| (3-aminophenyl)(morpholino)methanone | 104775-65-7 | 2A-9090701 |
| N-(4-(pyrrolidin-1-yl)phenyl)acetamide | 52373-51-0 | 2A-9090704 |
| N-ISOPROPYLACETAMIDE | 1118-69-0 | 2A-9090709 |
| METHYLHIPPURATE | 1205-08-9 | 2A-9090713 |
| CYCLOHEXYLCARBANILATE | 3770-95-4 | 2A-9090718 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA